Alisha Scoggin Coker

Business Development Manager at Med Communications, Inc.

Alisha Scoggin Coker is a seasoned business development manager at Med Communications, Inc. since January 2015, specializing in partnerships within the pharmaceutical, biotech, and medical device sectors. Prior to this role, Alisha served as an Executive Urology Specialty sales representative at Astellas Pharma from November 2006 to January 2015, where responsibilities included increasing market share and leading primary care representatives. Alisha's experience also encompasses medical device sales at Johnson & Johnson from 2004 to 2006, where engagement with healthcare professionals included educational training on various medical technologies, and a role at AstraZeneca Pharmaceuticals as a pharmaceutical sales representative from 1998 to 2004. Alisha holds a Bachelor of Business Administration in Marketing from The University of Memphis, obtained in 1995.

Location

Memphis, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


Med Communications, Inc.

1 followers

Med Communications is a leading provider of global medical affairs services to the pharmaceutical, biotechnology, and medical device industries. For over 25 years, we have specialized in medical information contact center support, medical writing, promotional review, and pharmacovigilance. Our clinically trained staff has expertise in the following therapeutic areas: -Allergy/ENT -Cardiology -Endocrinology -Gastroenterology -Hematology/Oncology -Infectious Disease -Nephrology -Neurology/CNS -Pulmonology -Women's Health Further specialized pharmacologic specialties and treatment areas include: -Biologics -Gene Editing -Medical Devices -Orphan Drugs & Rare Diseases -Vaccines Each member of our professional staff has industry, clinical, or academic training, and nearly a third of our pharmacists have experience in all 3 areas of expertise. Working with a team of highly skilled professionals is critical at every stage of the drug development process.


Employees

201-500

Links